Strategies of Influence: How Corporate Power Directs and Constrains the FDA

DSpace/Manakin Repository

Strategies of Influence: How Corporate Power Directs and Constrains the FDA

Citable link to this page

. . . . . .

Title: Strategies of Influence: How Corporate Power Directs and Constrains the FDA
Author: Solet, David M.
Citation: Strategies of Influence: How Corporate Power Directs and Constrains the FDA (2001 Third Year Paper)
Full Text & Related Files:
Abstract: This paper is about the Food and Drug Administration, and the tactics that regulated – and sometimes unregulated – industries use to influence that agency’s decision-making process. Many of these tactics are legal; others are illegal, but difficult to recognize and police. In virtually every case, the purpose of these tactics is to undermine the neutral and detached scientific processes to which the FDA aspires, in order to advance the financial interests of regulated industries. While some of the details recounted herein are gravely disturbing, even outrageous, the purpose of this paper is not to moralize, but to identify these tactics and assess them in a neutral fashion, in order that they may offer some lesson about the systemic structures that created them
Terms of Use: This article is made available under the terms and conditions applicable to Other Posted Material, as set forth at http://nrs.harvard.edu/urn-3:HUL.InstRepos:dash.current.terms-of-use#LAA
Citable link to this page: http://nrs.harvard.edu/urn-3:HUL.InstRepos:8846804

Show full Dublin Core record

This item appears in the following Collection(s)

 
 

Search DASH


Advanced Search
 
 

Submitters